Tech Company Financing Transactions
Genomatica Funding Round
Novo Ventures, Casdin Capital and private investors participated in a $118 million Series C venture round for Genomatica. The round was recorded on 7/28/2021.
Transaction Overview
Company Name
Announced On
7/28/2021
Transaction Type
Venture Equity
Amount
$118,000,000
Round
Series C
Investors
Proceeds Purpose
Genomatica will use the investment to scale production for its portfolio of products and continue investing in new technologies to amplify the impact of sustainable materials across a range of industries.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4757 Nexus Center Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Genomatica is a leader in sustainable chemicals: greener intermediate and basic chemicals made from renewable feedstocks, rather than oil and gas. High-volume core products with better economics and smaller environmental footprint.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Carlos Cabrera
Chief Executive Officer
Christophe Schilling
Browse more venture capital transactions:
Prev: 7/28/2021: Dibbs venture capital transaction
Next: 7/28/2021: Fireblocks venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs